🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Roberto Passera

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

ORCID: 0000-0003-3372-2248

Also affiliated with Department of Medical Sciences, University of Turin

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial”.

[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial

EJNMMI Research(2020)10.1186/s13550-020-00715-0

N/A

0DataRank · unranked

15 citations

Francesco Ceci, Roberto Passera, Jacquelyn Crane, Lin Du, Gang Li +8 more

[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial

Research Square(2020)10.21203/rs.3.rs-36997/v2

N/A

0DataRank · unranked

0 citations

Francesco Ceci, Roberto Passera, Jacquelyn Crane, Lin Du, Gang Li +8 more

FDG PET/CT for Evaluating Early Response to Neoadjuvant Chemotherapy in Pediatric Patients with Sarcoma: A Prospective Single-Center Trial

Research Square(2020)10.21203/rs.3.rs-36997/v1

N/A

0DataRank · unranked

0 citations

Francesco Ceci, Roberto Passera, Jacquelyn Crane, Lin Du, Gang Li +8 more